Ensitrelvir
Chemical compound
Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.
Nº Q110798570 ★★
Incomum · Saberes
Ensitrelvir
Chemical compound
Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor.
Último preço
—
Preço mínimo
—
Mediana 7 d
—
Vendas 30 d
0
Faixa 30 d
—
Em circulação
0
Cotação
mediana
mín – máx
vendas
Sem vendas no período
Ver tabela
| Data | mediana | Mín | Máx | vendas |
|---|
Histórico de vendas
- Última venda
- —
- Média 30 d
- —
- Mínima 30 d
- —
- Máxima 30 d
- —
- Vendas 7 d
- 0
- Vendas 30 d
- 0
Ainda sem vendas.
Vendas anônimas: sem comprador nem vendedor. Os números contam só vendas entre jogadores.
Na Wikipédia
Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.
Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent COVID-19 infections following exposure. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor. It is taken by mouth. The most common adverse events include transient decreases in high-density lipoprotein and increased blood triglycerides.
Texto: Wikipédia em inglês, CC BY-SA 4.0. · Imagem: User:Innerstream (Public domain) ·
